ClinicalTrials.gg
Not yet recruitingNCT07747753NaoclUpdated Aug 5, 2026

Comparison of Post-operative Pain and Levels of MMP -9 Following Root Canal Irrigation With Sodium Hypochlorite Versus Cold Atmospheric Plasma in Patient With Necrotic Single Rooted Teeth: Randomized Clinical Trial

An interventional study of Application of cold atmospheric plasma in Necrotic Pulp, sponsored by Ahmed Hesham Abdelmohaimen Rezk. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by Ahmed Hesham Abdelmohaimen Rezk · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 43 studies in Dental Pulp Necrosis with a site in Egypt — 12 open to participants now, 16 under way, 1 of them phase 3. Dental Pulp Necrosis · Egypt.

Planned enrollment
8th of 43
60 · median 40
Started
2026
with 6 others
No phase
31 of 43
9 open now
Primary completion
2027-01
later than 8 of 15 live
Registered
40th of 43
by date
Lead sponsor
1 of 43
Ahmed Hesham Abdelmohaimen Rezk

Among the 43 studies in Dental Pulp Necrosis with a site in Egypt, this one is the 8th largest by planned enrollment, is one of 7 that started in 2026, is one of 31 with no phase, reaches primary completion later than 8 of the 15 other live ones, and was the 40th registered.

Dental Pulp Necrosis

157 studies on the registry are indexed under Dental Pulp Necrosis; 44 are open to participants now.

Browse Dental Pulp Necrosis studies →

Open to participants now

12 of the 43 studies in Dental Pulp Necrosis with a site in Egypt are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 15 Dental Pulp Necrosis studies recruiting now, 6 (40%) set no upper age limit and 7 (47%) stop at 75 or younger; 4 take children under 18; 5 take healthy volunteers.

This study: 18 Years to 55 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 43 studies in Dental Pulp Necrosis with a site in Egypt, or all of them as a file.
02

Study summary

The goal of this clinical trial is to compare the effect of cold atmospheric plasma versus sodium hypochlorite as irrigating solutions in necrotic single rooted teeth. The main questions it aims to answer are:

  • Does the use of sodium hypochlorite solution or cold atmospheric plasma as root canal irrigant will have the same effect on the level of postoperative pain in necrotic single rooted teeth?
  • Does the use of sodium hypochlorite solution or cold atmospheric plasma as root canal irrigant will have the same effect on the level of MMP -9 in necrotic single rooted teeth? Researchers will compare cold atmospheric plasma to sodium hypochlorite solution as root canal irrigant to see if cold atmospheric plasma works to have the same effect on the level of postoperative pain and levels of MMP -9 in necrotic single rooted teeth.

Participants will:

  • be asked to rate their pain level according to the given instructions and will be asked to return for follow up after 2 days to hand the pain scale chart.
  • be instructed to call the operator and will be permitted to take Ibuprofen 400 mg not more than 6 hours apart and to record their tablet intake within 48 hours postoperatively, in case of severe or persistent pain.
  • be referred to the fixed prosthodontics department for final restoration.
Read the detailed description

The study will be carried out in the endodontic clinic at the faculty of dentistry, Cairo University, Cairo governorate, Egypt.

  • The dental Unit is ADEC 200 USA.
  • The X-ray machine is FONA XDC, Italy.
  • The X-ray sensor plate: Digora intraoral digital sensor plate, Soredex, USA.
  • The operator is a PhD student in the department of Endodontics.
  • Time: 2025 Interventions

Operator qualifications:

PhD degree candidate.

  1. Diagnostic procedures:

    • Personal information (name, age, gender, address and phone number), full medical
    • (Appendix 2) and dental histories (Appendix 3) using schematic charts will be obtained from all patients participating in this research.
    • History of chief complaint will be obtained in the dental history chart.
    • Clinical and radiographic evaluation for each tooth included in this study will be recorded. The tooth will be examined for presence of extensive caries or pulp exposures. Soft tissue examination and tooth mobility evaluation will be done by percussion and palpation.
    • Extra oral examination will be performed by visual inspection of the face and neck and palpation for any swollen lymph nodes.
    • Each tooth will be evaluated for sensitivity using electric pulp tester. Diagnosis will also be confirmed by the absence of bleeding after access cavity preparation.
    • Final Diagnosis: necrotic mandibular premolar teeth is confirmed through history of chief complaint reporting no pain with hot and/or cold stimulus, negative response to an electrical pulp tester, and radiographic examination showing lower premolar with widening of periodontal membrane space and with/without periapical radiolucency (not exceeding 2*2 mm radiographically).
    • The operator will explicitly explain the trial steps to the patients, and an informed consent (Appendix 1) will be signed by patients who accept enrollment.

    Pain scale chart will be given to each patient after training to rate his /her pain level before endodontic treatment as preoperative reading using a Numerical Rating Scale (NRS) (Youssif et al. 2025).

  2. Endodontic procedures:

    First visit:

    • All the performed steps of root canal treatment will be included in the chart of endodontic procedures (Appendix 5).
    • Tooth will be anaesthetized using 4% articaine with 1:100000 epinephrine .
    • The tooth will be isolated with rubber dam to maintain aseptic field, after isolation the tooth and surrounding field will be disinfected by a protocol using 3% hydrogen peroxide for 30 s and 5.25% NaOCl before and after coronal access cavity preparation for 30 s, then 5% sodium thiosulphate will be used to inactivate the disinfecting agents (Rôças et al., 2016).
    • Access cavity will be performed using a round bur and an endo-z bur .
    • The first periapical sample (S-1) will be collected after access cavity preparation by flushing the canal with saline and a sterile paper point #15 or #20 for 30 seconds 2 mm beyond the canal terminus (Shimauchi et al, 1996). This procedure will be performed three times. The paper points will be placed in a sterile micro-centrifugation tube (2ml) (Merck), and immediately transferred to a 80 °C freezer until further processing. Paper points will be placed in the substrate solution and agitated for one hour on a platform shaker for protein extraction. Absorbance will be read at 450 nm using a micro-plate reader.
    • Working length determination will be established using an apex locator and confirmed with a periapical radiograph, ensuring it is 0.5 mm short of the radiographic apex.
    • Mechanical preparation will be performed up to #F4 file for all the cases with rotary nickel-titanium instruments in an X-Smart endodontic motor .
    • The canals will be thoroughly irrigated between every two subsequent files using 2 ml of 2.5% NaOCl using a side vented needle (gauge 27) to control the possibility of irrigant apical extrusion.
    • After complete root canal preparation all canals will be flushed with 17 % EDTA followed by 2.5% NaOCl then 5 ml saline to inactivate the NaOCl.
  3. Random allocation:

    • According to the randomization sequence, after complete root canal preparation patients will be assigned to one of 2 groups:

      • Intervention Group (G1): each canal will be received cold atmospheric plasma using Maglev plasma pen inserted 1 ml shorter than the working length with special tip for five minutes (Küçük et al., 2020).
      • Comparator Group (G2): each canal will be flushed using 5 ml of 2.5% sodium hypochlorite in a plastic syringe with side vented needle (gauge 27) inserted 1 ml shorter than the working length.
    • After application of the two disinfection protocols the second periapical sample (S-2) will be taken and handled as mentioned before, the access cavities will be sealed by glass ionomer without the use of intracanal medication. The patients will be scheduled for recall after one week.
    • Treatment of all participants will be done in in two visits and the patients will record their degree of pain following disinfection protocol in the first visit and after obturation in the second visit on NRS at 6, 12, 24 and 48 hours.

    Second visit:

    • The canals will be re-entered under rubber dam isolation, to obtain the third periapical sample (pre-obturation) (S-3), that will be taken and handled as mentioned before.
    • Obturation: drying of the canals will be done using paper points matching the final apical file size. A radiograph will be obtained to ensure proper master cone extension.
    • Each root canal will be obturated with modified single cone technique using the ProTaper Universal gutta-percha points size F4 and gutta-percha points size 25 as auxiliaries with resin-based sealer together with auxiliary cones ISO # 25/0.02.
    • After obturation, the access cavity will be sealed with a glass ionomer.
    • Samples will be collected after root canal preparation (S-1), after application of the two disinfection protocols (S-2), and after one-week pre-obturation (S-3) and transferred immediately to microbiology Laboratory, faculty of Medicine, Cairo University, to be analysed and tested.
  4. Postoperative instructions will be given to all patients:

    • The patient will be asked to rate their pain level according to the given instructions and will be asked to return for follow up after 2 days to hand the pain scale chart.
    • In case of severe or persistent pain, they will be instructed to call the operator and will be permitted to take Ibuprofen 400 mg not more than 6 hours apart and to record their tablet intake within 48 hours postoperatively.
    • The patients will be referred to the fixed prosthodontics department for final restoration.

12. Outcomes: Primary outcome

Postoperative pain intensity will be measured at 6, 12, 24 and 48 hours and one week after the two visits following disinfection protocol in the first visit and after obturation in the second visit:

Each patient will receive a pain chart containing 4 numerical rating scales; one for each time interval. The patient will be instructed to rate his/her pain level at the corresponding time interval on a scale from zero to 10, where a score of zero indicates absence of pain, a score from 1 to 3 indicates mild pain, a score from 4 to 6 indicates moderate pain and a score from 7 to 10 indicates severe pain (Youssif et al. 2025).

Secondary outcome:

Periapical MMP-9 level will be determined using the absorbance ELISA after access cavity preparation (S-1), after application of disinfection protocol (S-2) and after one-week pre-obturation (S-3) (Abdel-Hamid et al. 2024).

03

Conditions studied

  • Necrotic Pulp

Keywords

  • cold atmospheric plasma
  • post-operative pain
  • necrotic pulp
  • sodium hypochlorite
  • MMP
04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients in good physical health; (ASA) class I or II, with no known allergic manifestations to the drugs used in the study and no involvement with other medication during the study (Appendix)
  2. Patient's age between 18-55 years.
  3. Male and female patients.
  4. Patients who can understand the numerical rating scale (Appendix 4).
  5. Patients who accept to participate in the trial and can sign the (Appendix 1).
  6. Mature mandibular premolar teeth with:

    • Negative response to electric pulp tester.
    • No intra-canal calcifications or internal resorptive lesions.

Exclusion criteria

Exclusion Criteria:

  1. Medically compromised patients having substantive functional limitations () (Appendix 2).
  2. Patients having two or more adjacent teeth requiring endodontic treatment.
  3. Patients who received antibiotic therapy within the last three months before treatment (Rôças et al., 2016).
  4. Patients administered analgesics in the last 24 hours before treatment.
  5. Teeth with:

    • Vital pulps.
    • Immature apices.
    • Acute periapical abscess, swellings and facial cellulitis.
    • Periodontally affected (mobility grade II or III).
    • Previous root canal treatment.
    • Non-restorable coronal portion.
  6. TMJ problems, bruxism or traumatic occlusion.
  7. Inability to perceive the given instructions.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Application of cold atmospheric plasma

    root canal disinfection protocol

    Other: Application of cold atmospheric plasma

  • Active comparator
    2.5% sodium hypochlorite

    irrigation solution

    Other: Application of cold atmospheric plasma

Interventions

  • OtherApplication of cold atmospheric plasma

    root canal disinfection protocol

06

What researchers measure

Primary outcomes

  1. Post-operative pain

    Postoperative pain intensity will be measured at 6, 12, 24 and 48 hours and one week after the two visits following disinfection protocol in the first visit and after obturation in the second visit: Each patient will receive a pain chart containing 4 numerical rating scales; one for each time interval. The patient will be instructed to rate his/her pain level at the corresponding time interval on a scale from zero to 10, where a score of zero indicates absence of pain, a score from 1 to 3 indicates mild pain, a score from 4 to 6 indicates moderate pain and a score from 7 to 10 indicates severe pain (Youssif et al. 2025).

    Time frame: 6,12,24,48 hours and 7 days postoperative following the two visits.

Secondary outcomes

  1. MMP-9 level

    Periapical MMP-9 level will be determined using the absorbance ELISA after access cavity preparation (S-1), after application of disinfection protocol (S-2) and after one-week pre-obturation (S-3) (Abdel-Hamid et al. 2024).

    Time frame: After access cavity preparation (S-1), after application of disinfection protocol (S-2) & after one-week pre-obturation (S-3)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Jan 2027, 5 months later.

Of 66 non-industry interventional studies with no phase under Dental Pulp Necrosis, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 5 months is below that.

Counting every sponsor, half of 67 studies reached it within 15 months; a quarter within 9 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 31, 2026
First posted
Aug 5, 2026
StartEst.
Aug 2026
Primary completionEst.
Jan 2027
CompletionEst.
Mar 2027
Last update
Aug 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07747753
Lead sponsor
Ahmed Hesham Abdelmohaimen Rezk
Responsible party
Ahmed Hesham Abdelmohaimen Rezk (principle investigator, Cairo University) — Sponsor-investigator
First posted
Aug 5, 2026
Start date
Aug 2026 (estimated)
Primary completion
Jan 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Aug 5, 2026

Study contacts

Manar Yosri Fouda, Professor
Contact
manaryfouda@gmail.com
002 01001101108

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion